“…None of their patients required a subsequent stent or feeding tube placement, and they did not find any RT-related toxicity. They also evaluated the change in QoL, and at the end of the 3 rd month, they found a significant improvement in a number of QoL domains (dysphagia, eating, reflux, pain, and saliva) [7] According to the existing literature, curative chemoradiotherapy (CRT) is superior to RT alone regarding local control and overall survival for patients with nonmetastatic, unresectable EC [8][9][10]. The patients our study, however, were declared unsuitable for curative CRT due to a number of patient or disease-related factors, including poor general health, medical co-morbidities, extensive locoregional disease, or distant metastases.…”